In the study, the researchers examined the anti-obesity effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) in healthy adults with obese tendencies in a randomized controlled trial by measurement of abdominal fat area, body weight and other body measures, and serum adiponectin.
The probiotic LG2055 showed lowering effects on abdominal adiposity, body weight and other measures, suggesting its beneficial influence on metabolic disorders.